Fluvastatin as an adjuvant therapy with pegylated interferon and ribavirin in the treatment of chronic hepatitis C virus /
Haitham Ahmed Ali Gabr
Fluvastatin as an adjuvant therapy with pegylated interferon and ribavirin in the treatment of chronic hepatitis C virus / الفلوفاستاتين كعقار مساعد لعقاري الانترفيرون طويل المفعول و الريبافيرين فى علاج الالتهاب الكبدى الوبائى الفيروسي (سى) المزمن Haitham Ahmed Ali Gabr ; Supervised Zakaria A. Salama , Moataz Serry Seyam , Ahmed Fouad Soliman - Cairo : Haitham Ahmed Ali Gabr , 2013 - 288 P. ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
It could be argued that statins, besides a weak direct antiviral effect, may enhance HCV infectivity of hepatocytes through the decrease in circulating LDL levels and the up-regulation of LDL receptors. This effect of statins might counterbalance the antiviral activity described in the replicon models
Fluvastatin Statins and HCV Treatment of HCV
Fluvastatin as an adjuvant therapy with pegylated interferon and ribavirin in the treatment of chronic hepatitis C virus / الفلوفاستاتين كعقار مساعد لعقاري الانترفيرون طويل المفعول و الريبافيرين فى علاج الالتهاب الكبدى الوبائى الفيروسي (سى) المزمن Haitham Ahmed Ali Gabr ; Supervised Zakaria A. Salama , Moataz Serry Seyam , Ahmed Fouad Soliman - Cairo : Haitham Ahmed Ali Gabr , 2013 - 288 P. ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
It could be argued that statins, besides a weak direct antiviral effect, may enhance HCV infectivity of hepatocytes through the decrease in circulating LDL levels and the up-regulation of LDL receptors. This effect of statins might counterbalance the antiviral activity described in the replicon models
Fluvastatin Statins and HCV Treatment of HCV